Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to -$6.7 million.

  • Kewaunee Scientific's Net Cash Flow fell 24783.38% to -$6.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$15.6 million, marking a year-over-year decrease of 29828.77%. This contributed to the annual value of -$8.7 million for FY2025, which is 17150.37% down from last year.
  • Latest data reveals that Kewaunee Scientific reported Net Cash Flow of -$6.7 million as of Q4 2025, which was down 24783.38% from $3.6 million recorded in Q3 2025.
  • Kewaunee Scientific's 5-year Net Cash Flow high stood at $15.0 million for Q3 2022, and its period low was -$17.1 million during Q1 2025.
  • In the last 5 years, Kewaunee Scientific's Net Cash Flow had a median value of $24500.0 in 2021 and averaged $404150.0.
  • Over the last 5 years, Kewaunee Scientific's Net Cash Flow had its largest YoY gain of 636150.63% in 2022, and its largest YoY loss of 530526.32% in 2022.
  • Kewaunee Scientific's Net Cash Flow (Quarter) stood at $95000.0 in 2021, then crashed by 5305.26% to -$4.9 million in 2022, then soared by 105.34% to $264000.0 in 2023, then surged by 1613.64% to $4.5 million in 2024, then plummeted by 247.83% to -$6.7 million in 2025.
  • Its Net Cash Flow stands at -$6.7 million for Q4 2025, versus $3.6 million for Q3 2025 and $4.6 million for Q2 2025.